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Abstract
We compared anesthetic features, blood parameters, and physiological responses to either
medetomidine-tiletamine-zolazepam or dexmedetomidine-tiletamine-zolazepam using a
double-blinded, randomized experimental design during 40 anesthetic events of free-rang-
ing brown bears (Ursus arctos) either captured by helicopter in Sweden or by culvert trap in
Canada. Induction was smooth and predictable with both anesthetic protocols. Induction
time, the need for supplemental drugs to sustain anesthesia, and capture-related stress
were analyzed using generalized linear models, but anesthetic protocol did not differentially
affect these variables. Arterial blood gases and acid-base status, and physiological
responses were examined using linear mixed models. We documented acidemia (pH of
arterial blood < 7.35), hypoxemia (partial pressure of arterial oxygen < 80 mmHg), and
hypercapnia (partial pressure of arterial carbon dioxide 45 mmHg) with both protocols.
Arterial pH and oxygen partial pressure were similar between groups with the latter improv-
ing markedly after oxygen supplementation (p < 0.001). We documented dose-dependent
effects of both anesthetic protocols on induction time and arterial oxygen partial pressure.
The partial pressure of arterial carbon dioxide increased as respiratory rate increased with
medetomidine-tiletamine-zolazepam, but not with dexmedetomidine-tiletamine-zolazepam,
demonstrating a differential drug effect. Differences in heart rate, respiratory rate, and rectal
temperature among bears could not be attributed to the anesthetic protocol. Heart rate
increased with increasing rectal temperature (p < 0.001) and ordinal day of capture (p =
0.002). Respiratory rate was significantly higher in bears captured by helicopter in Sweden
than in bears captured by culvert trap in Canada (p < 0.001). Rectal temperature
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significantly decreased over time (p 0.05). Overall, we did not find any benefit of using
dexmedetomidine-tiletamine-zolazepam instead of medetomidine-tiletamine-zolazepam in
the anesthesia of brown bears. Both drug combinations appeared to be safe and reliable for
the anesthesia of free-ranging brown bears captured by helicopter or by culvert trap.
Introduction
Capture, and anesthesia of wild mammals are required for conservation, research and manage-
ment purposes [1–3]. The use of anesthetic drugs helps to reduce the stress and pain caused by
capture and handling, while providing safety for capture personnel [4]. Brown bears (Ursus
arctos) have been anesthetized for management and conservation throughout their global
range using a variety of anesthetic agents. The most common protocols have combined a dis-
sociative agent with a benzodiazepine or an alpha-2 adrenoceptor agonist [5, 6].
Tiletamine, a dissociative anesthetic, combined in equal parts by weight with zolazepam, a
benzodiazepine agonist, has been used for many years in the anesthesia of brown bears, espe-
cially in North America [6]. Tiletamine-zolazepam (TZ) produces reliable anesthesia in bears,
has a wide safety margin, and causes minimal depression of the cardiovascular and respiratory
systems [7, 8]. However, use of TZ requires large drug volumes, provides poor visceral analge-
sia, and cannot be antagonized [6]. Another concern is extended recovery times, especially
when additional (top-up) doses of TZ are administered, exposing anesthetized bears to the
risks of inclement weather and predation [9, 10].
Combining TZ with medetomidine (M), an alpha-2 adrenoceptor agonist, counteracts
some of the undesired effects of TZ. Medetomidine-tiletamine-zolazepam (MTZ) can be deliv-
ered at approximately 25% of the volume of TZ alone [8]. Additionally, M improves analgesia
and reduces the effective TZ dose level (mg/kg) required by 75%. The effects of M can be spe-
cifically antagonized by atipamezole, an alpha-2 adrenoceptor antagonist [7], making MTZ a
“partially reversible” anesthetic protocol.
Medetomidine is a potent, selective, and specific alpha-2 adrenoceptor agonist composed
by equal parts of two optical enantiomers, dexmedetomidine and levomedetomidine [11]. The
pharmacological effects of M are due almost exclusively to dexmedetomidine [12, 13]. Levo-
medetomidine is considered an inactive ingredient [12], but may act as a weak partial alpha-2
adrenoceptor agonist or as an inverse alpha-2 adrenoceptor agonist [14], producing opposite
sedative and analgesic effects [13, 15].
Dexmedetomidine (D), the dextrorotatory enantiomer, has been used in recent years in the
anesthesia of a few wildlife species, including bears [16–20]. Dexmedetomidine combined
with TZ (DTZ) has been suggested to cause less respiratory depression than MTZ in bears
potentially offering a benefit of using D instead of M [21, 22].
Our study goal was to determine whether DTZ offers any advantage over MTZ in the anes-
thesia of free-ranging brown bears by comparing induction times, the need for supplemental
drugs to sustain anesthesia, stress as quantified by serum cortisol concentrations, arterial
blood gases, acid-base status, and physiological responses between anesthetic protocols. To
our knowledge, this is the first double-blinded, randomized comparison of the effects of DTZ
and MTZ in ursids. We hypothesized that:
1. Induction time—The induction of anesthesia occurs faster with DTZ than with MTZ.
Quick inductions reduce the potential for physical injury and physiological stress. Shorter
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induction times have been reported in golden-headed lion tamarins (Leontopithecus chry-
somelas) anesthetized with D-ketamine compared to M-ketamine [16].
2. Duration of anesthesia—The need for supplemental drugs to sustain anesthesia is lower
with DTZ than MTZ.
Drugs used in wildlife anesthesia should provide enough depth and duration of anesthesia
to perform all planned handling procedures without the administration of supplemental
(also referred to as top-up) drugs. Further, the supplemental administration of TZ may
result in prolonged recoveries [9, 10]. Studies have discovered a longer lasting anesthetic
effect of D over M [16].
3. Stress—Stress in response to capture and handling is lower with DTZ than MTZ.
Blood concentrations of cortisol, and glucose to a lesser extent, are widely-used parameters
to assess the stress response to capture and handling in free-ranging wild animals [23, 24].
Medetomidine has been shown to cause greater increases in serum glucose concentration
than D [25]. Although the effects of alpha-2 adrenoceptor agonists on cortisol concentra-
tions are controversial [26, 27], we hypothesized that serum concentrations of cortisol, as
an indicator of stress, would be less with DTZ.
4. Arterial blood gases and acid-base status—Bears anesthetized with DTZ have higher pH
and partial pressure of arterial oxygen (PaO2), and lower partial pressure of arterial carbon
dioxide (PaCO2) than bears anesthetized with MTZ.
Hypoxemia (PaO2 < 80 mmHg) is a common finding in bears anesthetized with MTZ [28,
29]. DTZ, however, was reported to not cause hypoxemia in a study of brown bears [21].
Although pH and blood gases are not routinely recorded in wildlife studies, they provide a
valuable physiological assessment of an animal’s response to capture and anesthesia.
5. Physiological responses—DTZ produces less cardio-respiratory depression and quicker
recovery of normal body temperature than MTZ.
Ideally, anesthetic drugs should cause minimal depression of the cardiovascular and respi-
ratory systems, and should not suppress the dissipation of excess body heat caused by physi-
cal exertion and stress. Several studies have suggested that D has minimal effects on these
physiological variables [18, 21].
Material and Methods
Scandinavian Brown Bear Research Project (SBBRP)
We captured 31 individual free-ranging brown bears on 34 occasions in Dalarna County, Swe-
den (61.219756–61.579688 N, 13.019778–15.416586 E) in April-July 2014 and April-May
2015. We applied a randomized, double-blinded design in which 15 individuals were allocated
to the MTZ group and 16 to the DTZ group. Three bears were captured twice, once per year,
with one bear receiving MTZ followed by DTZ, another receiving DTZ followed by MTZ, and
the third receiving DTZ both years. Consequently, the MTZ group comprised 16 anesthetic
events and the DTZ group comprised 18 anesthetic events. When two or more bears were
together at the time of capture (i.e., family groups), we randomly used one of the study drug
combinations for the first bear and alternated the drug for the accompanying bear(s). Cap-
tured bears in this study were composed of 16 males and 15 females with 19 bears captured as
yearlings, nine bears captured as two year olds, and three captured at both ages. We did not
capture larger bears because our dart volumes were limited to3 ml and because access to D
in Sweden was limited to a low concentration (0.5 mg/ml) drug solution.
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For yearlings, we prepared MTZ by adding 5 mg of M (Domitor1 1 mg/ml per 10 ml per
vial, Orion Pharma Animal Health, Turku, Finland) to a vial of TZ (Zoletil1 500 mg/vial, Vir-
bac, Carros, France). We split the solution into six 1.5 ml darts, each dart containing 0.83 mg
of M and 83.3 mg of TZ. The remaining 5 mg of M were equally divided and added to each
dart (0.83 mg of M per dart). The final solution contained 1.66 mg of M and 83.3 mg of TZ in
each dart, with a M:TZ ratio of 1:50. We prepared DTZ in the same way as described above
adding 2.5 mg of D (Dexdomitor1 0.5 mg/ml per 10 ml per vial, Orion Pharma Animal
Health) to a vial of TZ. We split the solution into six darts, each dart containing 0.415 mg of D
and 83.3 mg of TZ. The remaining 2.5 mg of D were equally divided and added to each dart
(0.415 mg of D per dart). The final solution contained 0.83 mg of D and 83.3 mg of TZ in each
dart, with a D:TZ ratio of 1:100. For two-year-old bears, we prepared both drug combinations
as described for yearlings, but divided the initial solution of M or D and TZ, and the remaining
M or D into four 3 ml darts. The final solution contained 2.5 mg M or 1.25 mg D and 125 mg
TZ in each dart, again with a M:TZ ratio of 1:50, and a D:TZ ratio of 1:100. The dose for each
age class remained unchanged throughout the study.
We administered the anesthetic combination by remote delivery from a CO2-powered rifle
(Dan-Inject1, Børkop, Denmark) at a distance of 3–7 meters from a helicopter. Darts used in
the study consisted of 1.5 ml syringes with 1.5x25mm barbed needles with side ports (Dan-
Inject1) in yearlings, and 3 ml syringes with 2.0x30mm needles in two-year-old bears. When
needed, 1–2 mg/kg of ketamine (Narketan1 100 mg/ml, Chassot, Dublin, Ireland) was admin-
istered intravenously or intramuscularly by syringe and needle to extend the duration of
anesthesia.
The time intervals in minutes (min) from when a bear was first observed to when a bear
was hit by a drug-filled dart (observed-darted time), from when active pursuit with the heli-
copter began to when the bear was darted (chased-darted time), and from when a bear was
darted to recumbency (induction time) were recorded. We recorded capillary refill time (sec-
onds), respiratory rate (breaths per min), heart rate (beats per min) and rectal temperature
(˚C) of anesthetized bears immediately after induction and every 15 min throughout the dura-
tion of anesthesia. Respiratory rate was monitored by observation of thoracic movements and
heart rate by auscultation of the heart. Rectal temperature was measured with a digital ther-
mometer (Accutemp1, Jahpron Medical Int., Jensvoll, Norway). When hyperthermia
( 40˚C) occurred, we applied snow to the paws, groin and axillae, and administered intrave-
nous fluids to reduce body temperature.
We collected one venous blood sample (8 ml) from the jugular vein of each bear as early as
possible following induction using a vacutainer system (BD Vacutainer1, BD Diagnostics,
Preanalytical Systems, Franklin Lakes, NJ, USA). We measured serum cortisol concentration
(nmol/L) with this sample [30]. We also collected two anaerobic arterial blood samples (3 ml
each) from the femoral artery of each bear in pre-heparinized syringes (PICOTM70, Radiome-
ter Copenhagen, DK-2700 Brønshøj, Denmark), the first at 30 min, and the second at 60 min,
after the bear was darted. We measured blood gases, acid-base status and selected hematologic
and biochemical variables on site using a portable analyzer (iSTAT 11Portable Clinical Ana-
lyzer and i-STAT1 cartridges CG4+ and 6+, Abbott Laboratories, Abbott Park IL, 60064–
6048, USA). The parameters included pH, partial pressure of arterial carbon dioxide (PaCO2;
mmHg), partial pressure of arterial oxygen (PaO2; mmHg), base excess (BE; mmol/L), bicar-
bonate (HCO3; mmol/L), total carbon dioxide (TCO2; mmol/L), arterial oxygen saturation
(SaO2; %), lactate (mmol/L), sodium (mmol/L), chloride (mmol/L), potassium (mmol/L),
blood urea nitrogen (BUN; mg/dL), glucose (mmol/L), hematocrit (% packed cell volume),
and hemoglobin (g/dL). Blood gas values and pH were corrected to the rectal temperature.
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Bears are routinely supplemented with intranasal oxygen throughout anesthesia, as part of
the standard field procedure of the SBBRP [31]. However, for this study, we only administered
oxygen to bears with low levels of blood oxygen (hypoxemia) based on PaO2 measurements.
Below 80 mmHg, we considered bears to be hypoxemic and administered oxygen at a flow rate
of 0.5 L/min in yearlings and 1L/min in two-year-old bears [29].
We performed different types of surgery (i.e., abdominal, muscle biopsy) on selected bears
to meet the research objectives of other studies. In bears undergoing surgery, we preemptively
administered 0.2 mg/kg of meloxicam (Metacam1 5 mg/ml, Boehringer Ingelheim, Reihn,
Germany) subcutaneously to reduce pain and inflammation caused by the surgery. We fol-
lowed a standard protocol for other sampling and handling procedures [31]. Body weight was
obtained by suspending bears from a spring-loaded scale to accurately determine drug dose
levels (mg/kg of body weight).
After completion of all procedures, we administered 5 mg of atipamezole (Antisedan1 5
mg/ml, Orion Pharma Animal Health) per mg of M or 10 mg of atipamezole per mg of D
intramuscularly to reverse anesthesia. We recorded the time interval in min from recumbency
to atipamezole administration (handling time), and left bears to recover undisturbed at the site
of capture.
Brown bear captures occurred both on private and public lands. Captures were approved
by the Swedish Ethical Committee on Animal Research (application numbers C 7/12 and C
18/15) and the Swedish Environmental Protection Agency (NV-0758-14).
fRI Research Grizzly Bear Program (fRI)
We captured six free-ranging adult (6–15 years) male brown bears in western Alberta, Canada
(52.865360–54.368277 N, 117.865738–119.017687 E) in May 2014–2015 by barrel (culvert)
trap [32]. We applied a randomized, double-blinded study in which three bears were allocated
to the MTZ group and three to the DTZ group. We prepared MZT by adding 12 mg of M (20
mg/ml; Chiron Compounding Pharmacy Inc., Guelph, Ontario, Canada) and 0.9 ml of sterile
water for injection (Hospira 10 ml per vial, Montreal, Quebec, Canada) per vial of TZ (Tela-
zol1, 286 mg tiletamine + 286 mg zolazepam; Fort Dodge Laboratories, Inc., Fort Dodge,
Iowa, U.S.A.). DZT was prepared in 2014 by adding 5.7 mg of D (3 mg/ml; Chiron Com-
pounding Pharmacy Inc.) and 0.2 ml of sterile water for injection per vial of Telazol1. In 2015,
we used 6 mg of a higher concentration of D (5 mg/ml), plus 0.9 ml of sterile water for injec-
tion, per vial of Telazol1. All formulations resulted in 2.5 ml of drug solution per vial with
concentrations of 234 mg/ml for MTZ and 231 mg/ml for DTZ, and ratios of 1:48 for M:TZ
and 1:95 for D:TZ.
We used a remote drug delivery system (Dan-Inject1) to administer a combination of
50μg/kg estimated body weight of M, or 25μg/kg of D, and 2.45 mg/kg of TZ intramuscularly.
Darts used in the study consisted of 3 ml syringes with 2.0x40mm barbed needles (Dan-
Inject1). When necessary, we administered ketamine at 2 mg/kg (200 mg/ml; Chiron Com-
pounding Pharmacy Inc.) intramuscularly by syringe and needle to extend the duration of
anesthesia.
We recorded the induction time for each bear. Capillary refill time, respiratory rate, heart
rate, and rectal temperature of anesthetized bears were obtained immediately after induction
and every 15 min throughout anesthesia. Respiratory rate was monitored by observation of
thoracic movements. We recorded pulse rate and hemoglobin oxygen saturation (SpO2; %)
with a pulse oximeter (Nellcor NPB-40, Nellcor, Pleasanton, California, U.S.A). Rectal temper-
ature was measured with a digital thermometer (Adtemp V Fast Read Pen Type Digital Ther-
mometer, American Diagnostic Corporation, New York, U.S.A).
Comparative Anesthesia in Bears
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We collected one venous blood sample (4 ml) from the femoral vein of each bear to mea-
sure cortisol concentrations (nmol/L; Immulite 1000; Siemens Medical Solutions Diagnostics,
California, U.S.A). We also collected two anaerobic arterial blood samples (3ml each) from the
femoral artery of each bear in pre-heparinized syringes 30 and 60 min after the bear was
darted. We used the same equipment and measured the same parameters as previously
described. Blood gas values and pH were corrected to the rectal temperature. Although oxygen
was available, we did not administer it to any of the bears captured in Alberta, Canada.
We extracted a premolar tooth for age estimation by counting cementum annuli [33]. We
administered 0.1 mg/kg of meloxicam (Metacam1, 5mg/ml solution for injection; Boehringer
Ingelheim Vetmedica Inc., Missouri, U.S.A) subcutaneously to provide analgesia. We weighed
all bears with an electronic load-cell scale.
After completion of measurements and sampling, we administered 5 mg of atipamezole (20
mg/ml; Chiron Compounding Pharmacy Inc.) per mg of M or 10 mg of atipamezole per mg of
D intramuscularly for anesthetic reversal. Bears were left to recover from anesthesia undis-
turbed at the site of capture. We recorded the handling time, and the time interval from atipa-
mezole administration until the bear showed the first signs of recovery (recovery time, in min).
Brown bear captures were authorized under the permitting authority of the Alberta Depart-
ment of Environment and Sustainable Resource Development (provincial jurisdiction lands),
Alberta Tourism and Parks (provincial parks and protected areas jurisdiction lands), and
Parks Canada (federal jurisdiction lands). Captures were approved by the University of Sas-
katchewan’s Committee on Animal Care and Supply (Animal Use Protocol # 20010016) and
were in accordance with guidelines provided by the American Society of Mammalogists’ Ani-
mal Care and Use Committee [3] and the Canadian Council on Animal Care for the safe han-
dling of wildlife [34].
Statistical analysis
We approached the statistical analyses in three sequential phases, data exploration, model
development, and model validation, using the software R 3.1.0 [35]. For data exploration, we
evaluated the raw data for (i) missing values, (ii) presence of outliers, (iii) collinearity among
potential predictor (independent) variables, and (iv) relationships or associations between
response (dependent) and predictor variables [36]. We used mean values to substitute for
missing values (i.e., we substituted two missing induction times when used as predictors with
the mean value). Collinearity among predictor variables was evaluated by variance inflation
factors (VIF 3.0) and pairwise correlations (r 0.7). Collinear variables were not used
together in the same model. We standardized continuous predictor variables (covariates) prior
to model development to facilitate comparisons among different models [37].
For model development, we worked with two different data sets. The first, containing data
collected in Sweden only, and the second, combined datasets containing data collected both in
Sweden and Alberta. We carried out different analyses for each of the hypotheses to be tested
(Table 1). For the induction time, the need for supplemental drugs and stress hypotheses (i.e.
Hypotheses 1–3), we used the ‘dredge’ function in package MuMin [38] to build all possible
models containing a maximum of 3 (Swedish dataset) or 4 (combined datasets) predictor vari-
ables to avoid model overfitting. With the same goal, we also did not evaluate possible interac-
tions. Model selection was based on the Akaike’s Information Criterion (AIC) [39]. For
evaluation of the arterial blood gases and acid-base status, and physiological responses hypoth-
eses (i.e. Hypothesis 4 and 5), we build multiple global models for each response variable to
avoid collinearity (i.e., predictor collinear variables were not used together in the same model).
We selected the most parsimonious (based on AIC) of these models for further analysis. Then
Comparative Anesthesia in Bears
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we applied the ‘drop 1’ function [40] to obtain the final model. However, before dropping a
predictor variable, we also evaluated it for any two-way interactions of potential physiological
significance, e.g., drug combination x respiratory rate.
For model validation, we plotted the standardized residuals of the best model against the fit-
ted values to assess homogeneity. If a pattern was observed in the spread, we applied a transfor-
mation to the response variable.
We present the mean ± standard deviation for all variables, unless otherwise stated. Differ-
ences were considered significant when p 0.05.
Results
Hypothesis 1: The induction of anesthesia occurs faster with DTZ than
MTZ
We used a single dart in the anesthesia of 30 bears (88%) in Sweden. Four bears (12%, two
bears in each drug group) required an additional dart to achieve anesthesia. Bears allocated to
Table 1. Response and predictor variables (interactions not shown), model types, and sample sizes (N) used to test hypotheses in brown bears
anesthetized with either medetomidine-tiletamine-zolazepam (MTZ) or dexmedetomidine-tiletamine-zolazepam (DTZ) in Sweden (S, N = 34) and
Alberta, Canada (A, N = 6) in 2014–2015.
Hypotheses Response
variablea
Predictor variableb combinations Random
effectsc
Model typed N
1 Induction time Age + Sex + Drug + TZ + CD time + ODCe NA GLM Gamma
link inverse
S = 34, S+A = 38
2 Supplemental
drugs
Age + Sex + Drug + Weight + CD time + ODC + Induction time +
Surgery + Handling timee
NA GLM binomial S = 34, S+A = 40
3 Cortisol Age + Sex + Drug + Weight + CD time + ODC + Induction timee,f NA GLM Gaussian S = 34, S+A = 39
4 pH Time + Age + Drug + PaCO2 + BE + Lactate Bear ID LMM S = 64, S+A = 76
4 PaO2 Age + Drug + Length + RT + RR + Oxygen Bear ID LMM S = 64, S+A = 76
4 PaCO2 Age + Drug + Weight + RT + RR + PaO2 Bear ID LMM S = 64, S+A = 76
5 Heart rate Time + Age + Sex + Drug + Length + CD time + ODC + Induction
time + Surgery + Ket + RT + RRe
Bear ID LMM S = 223, S+A = 165
5 Respiratory
rate
Time + Age + Sex + Drug + Length + CD time + ODC + Induction
time + Surgery + Ket + RT + HRe,f
Bear ID LMM S = 224, S+A = 167
5 Rectal
temperature
Time + Age + Sex + Drug + Weight + CD time + ODC + Induction
time + Surgery + Ket + HR + RRe
Bear ID LMM S = 223, S+A = 165
a Response variables—(i) Induction time: time interval in minutes from when a bear was darted to recumbency; (ii) Supplemental drugs: yes, no; (iii)
Cortisol: serum concentration in nmol/L; (iv) pH: arterial blood acid-base status; (v) PaO2: partial pressure of arterial oxygen in mmHg; (vi) PaCO2: partial
pressure of arterial carbon dioxide in mmHg; (vii) Heart rate (HR): beats per minute; (viii) Respiratory rate (RR): breaths per minute (log-transformed); and
(ix) Rectal temperature (RT): ˚C.
b Predictor variables—(i) Age: yearlings, two year olds, adults (5 yr); (ii) Sex: male, female; (iii) Drug: MTZ or DTZ in mg/kg body weight; (iv) TZ: tiletamine-
zolazepam in mg/kg body weight; (v) CD time: time interval in minutes from when active pursuit began to when the bear was darted; (vi) ODC: ordinal day of
capture; (vii) Weight: body weight in kg; (viii) Surgery: yes or no; (ix) Handling time: time interval in minutes from recumbency to atipamezole administration;
(x) Area: Sweden, Alberta; (xi) PaCO2; (xii) Time: sampling and/or measurements recorded at 15; 30; 45; 60; 75; 90; 105; 120; 135 minutes after darting in
Sweden, and at 15; 30; 45; 60; 75 minutes after darting in Sweden+Alberta; (xiii) BE: base excess in mmol/L; (xiv) Lactate: blood concentration in mmol/L;
(xv) Length: contour body length in cm; (xvi) RR: respiratory rate; (xvii) RT: rectal temperature; (xviii) Oxygen: yes or no; (xiv) PaO2; (xx); Ket: ketamine
dose level in mg/kg body weight; (xxi) HR: heart rate; (xxii) RR: respiratory rate; (xxii) RT: rectal temperature
c NA: not applicable.
d GLM: generalized linear model; LMM: linear mixed model.
e CD time was excluded as explanatory variable for the analysis of the Sweden+Alberta dataset.
f Area (Sweden; Alberta) substituted age as explanatory variable for the analysis of the Sweden+Alberta dataset
doi:10.1371/journal.pone.0170764.t001
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the MTZ group (N = 16) received an average dose level of 93.62 ± 36.96 μg/kg M and
4.69 ± 1.85 mg/kg TZ. Bears in the DTZ group (N = 18) received an average dose level of
57.51 ± 38.37 μg/kg D and 4.87 ± 2.49 mg/kg TZ. Induction of anesthesia was quick
(3.73 ± 2.81 min), predictable, and smooth in all bears irrespective of anesthetic protocol.
We used a single dart in the anesthesia of all bears captured by culvert trap in Alberta. Bears
allocated to the MTZ group (N = 3) received an average dose level of 52.23 ± 18.55 μg/kg M
and 2.5 ± 0.88 mg/kg TZ. Bears in the DTZ group (N = 3) received an average dose level of
21.97 ± 10.12 μg/kg D and 1.6 ± 0.78 mg/kg TZ. Induction of anesthesia was predictable and
smooth in all bears irrespective of anesthetic protocol, but mean induction time was longer
(6.25 ± 1.89 min) than recorded for bears in Sweden.
The induction time was significantly affected by TZ dose level, age, and sex (i.e., longer
induction with increasing TZ dose level, in two-year-old bears, and in males) (Table 2). For
the combined datasets, induction was faster in yearlings than in adult bears (Fig 1). Drug com-
bination did not have a significant effect on induction time, and was not included in the best
model. Thus, hypothesis 1 was not supported.
Hypothesis 2: The need for supplemental drugs to sustain anesthesia is
lower with DTZ than MTZ
We administered supplemental drugs to extend anesthesia in 21 (62%) bears in Sweden. Of
these, 11 bears belonged to the MTZ group, and 10 to the DTZ group. All bears but two
received ketamine (1.81 ± 0.5 mg/kg) as the supplemental drug. Of these two bears, one
showed signs of recovery 28 min after darting and received 2.55 mg/kg TZ. The other bear
only received 2/3 of the DTZ dose when darted. So, the remaining 1/3 (15.22 μg/kg D and 1.49
mg/kg TZ) was administered when it showed signs of recovery 45 min after darting. We
administered an average dose level of 2.22 mg/kg ketamine to extend anesthesia in two bears
from the DTZ group in Alberta.
Table 2. Regression coefficients (β) and significance (p) of the predictor variables in the best model explaining variation in the response variables
for hypotheses (H) 1, 2, 3 in brown bears anesthetized with either medetomidine-tiletamine-zolazepam (MTZ) or dexmedetomidine-tiletamine-zola-
zepam (DTZ) in Sweden (n = 34) and Alberta, Canada (n = 6) in 2014–2015.
H1: Induction time H2: Supplemental drugs H3: Cortisol
Sweden Sweden + Alberta Sweden Sweden + Alberta Sweden Sweden + Alberta
Predictorsa β p β p β p β p β p β p
Area (Sweden) -369.59 0.034
Age (Yearlings) 0.286 <0.001 14.081 0.147
Age (Two year olds) -0.199 0.002 0.094 0.090 18.850 0.102
Sex (Male) -0.150 0.012 -0.145 0.012 134.03 0.007 104.99 0.037
TZ dose level -0.051 <0.001 -0.049 <0.001
Weight 4.947 0.054 -86.07 <0.001 -163.84 0.009
Ordinal day of capture 36.267 0.093 18.695 0.088 -43.17 0.071
Induction time 46.54 0.045
Handling time 4.107 0.034 2.124 0.008
a Predictor variables–(i) Area: Sweden, Alberta; (ii) Age: yearlings, two year olds, adults (5 yr); (iii) Sex: male, female; (iv) TZ: tiletamine-zolazepam in mg/
kg body weight; (v) Weight: body weight in kg; (vi) Induction time: time interval in minutes from when a bear was darted to recumbency; (vii) Handling time:
time interval in minutes from recumbency to atipamezole administration. Regression coefficients for factors are relative coefficients such that: (i) β for Area
(Sweden) was determined with β for Area (Alberta) set to 0; β for Age (Two year olds) was determined with β for Age (Yearlings) set to 0 for the Sweden
dataset; (iii) β for Age (Yearlings) and for Age (Two year olds) were determined with β for Age (Adults) set to 0 for the Sweden + Alberta dataset; and (iv) β
for Sex (Male) was determined with β for Sex (Female) set to 0.
doi:10.1371/journal.pone.0170764.t002
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Handling time was the only variable that significantly influenced the need to administer
additional drugs such that the longer the handling time, the greater the likelihood of using
supplemental drugs to sustain anesthesia (Table 2). Because the need to administer supple-
mental drugs did not differ between DTZ and MTZ protocols, we did not find support for
hypothesis 2.
Hypothesis 3: Stress in response to capture and handling is lower with
DTZ than MTZ
Among brown bears in Sweden, blood cortisol concentrations were significantly higher in
bears that weighed less, in males, and in bears with longer inductions (Table 2). For the com-
bined datasets, study area was also a determining factor. Cortisol concentrations were signifi-
cantly higher in bears captured by culvert trap in Alberta than in bears captured by helicopter
in Sweden (Table 2). Anesthetic protocol did not have a significant effect on cortisol levels.
Therefore, hypothesis 3 was not supported.
Hypothesis 4: Bears anesthetized with DTZ have higher pH and partial
pressure of arterial oxygen (PaO2), and lower partial pressure of arterial
carbon dioxide (PaCO2) than bears anesthetized with MTZ
We documented acidemia (pH < 7.35), hypoxemia (PaO2 < 80 mmHg), and hypercapnia
(PaCO2 > 45 mmHg) as the main alterations in arterial blood gases and acid-base status using
both anesthetic protocols and in both study areas (S1 Text).
Arterial blood pH decreased with PaCO2 values and increased with BE values in both data-
sets (Table 3). However, pH was not affected by drug protocol in either dataset. Thus, hypothe-
sis 4 was not supported from the standpoint of our prediction that bears anesthetized with
DTZ would have higher pH values than bears anesthetized with MTZ.
Fig 1. Induction time (time interval from when a bear was darted to recumbency, in minutes) by tiletamine-zolazepam dose
level (in mg/kg body weight) and age class in 34 anesthetic events of free-ranging brown bears using a single dart of either
medetomidine-tiletamine-zolazepam or dexmedetomidine-tiletamine-zolazepam in Sweden and Alberta, Canada in 2014–
2015.
doi:10.1371/journal.pone.0170764.g001
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Arterial oxygen partial pressures (PaO2) were significantly correlated to the time interval
from darting to sampling time (r = 0.75 in Sweden, r = 0.68 in the combined datasets, p<
0.001). The PaO2 values were higher in two-year-old bears in the Swedish dataset, but age class
was not significant in the combined datasets (Table 3). Oxygen supplementation increased
PaO2 values in the Sweden bears (Table 3). Although oxygen supplementation was also signifi-
cant in the model describing the combined datasets, oxygen was not administered to bears in
Alberta. Arterial oxygen partial pressures decreased with increasing body length and increas-
ing rectal temperature in both datasets. However, PaO2 values were not affected by anesthetic
protocol in either dataset (Table 3). Thus, hypothesis 4 was not supported from the standpoint
of our prediction that bears anesthetized with DTZ would have higher PaO2 values than bears
anesthetized with MTZ.
Arterial carbon dioxide partial pressures (PaCO2) were higher in two-year-old bears than
yearlings, and decreased with increasing body weight and rectal temperature, in bears from
Sweden, but these associations were not evident in the combined datasets (Table 3). There
was a positive association between PaCO2 and PaO2 values, and a negative association
between PaCO2 values and respiratory rates, in both datasets. The latter association was also
significantly affected by anesthetic protocol in both datasets; PaCO2 values decreased as
respiratory rate increased in the DTZ group, but remained relatively constant with changes
in respiratory rate in the MTZ group (Table 3, Fig 2). Although not significant, there was a
trend towards increasing PCO2 values with increasing rectal temperatures in the MTZ group
in the combined datasets. These findings provide partial support for our prediction that
Table 3. Regression coefficients (β) and significance (p) of the predictor variables in the best model explaining variation in the response variables
for hypothesis (H) 4 in brown bears anesthetized with either medetomidine-tiletamine-zolazepam (MTZ) or dexmedetomidine-tiletamine-zolaze-
pam (DTZ) in Sweden (n = 34) and Alberta, Canada (n = 6) in 2014–2015.
H4: pH H4: PaO2 H4: PaCO2
Sweden Sweden + Alberta Sweden Sweden + Alberta Sweden Sweden + Alberta
Predictorsa β p β p β p β p β p β p
Age (Yearlings) -34.177 0.106
Age (Two year olds) 18.560 0.029 -19.3013 0.242 6.597 0.004
Sex (Male)
Drug (MTZ) 1.628 0.704 2.903 0.449 0.926 0.363 0.398 0.730
Weight -2.584 0.018
Length -8.181 0.044 -16.892 0.026
Rectal temperature -7.957 0.005 -6.478 0.004 -1.423 0.015 -0.715 0.231
Rectal temperature*MTZ 3.265 0.460 1.359 0.108 1.691 0.058
Respiratory rate 0.945 0.645 0.892 0.764 -1.867 0.001 -1.756 0.002
Respiratory rate*MTZ 0.326 0.928 2.078 0.004 0.662 0.006
PaCO2 -0.029 <0.001 -0.031 <0.001
BE 0.058 <0.001 0.058 <0.001
PaO2 1.755 <0.001 1.964 <0.001
Oxygen (Yes) 62.134 <0.001 62.288 <0.001
a Predictor variables–(i) Age: yearlings, two year olds, adults (5 yr); (ii) Sex: male, female; (iii) Drug: MTZ or DTZ in mg/kg body weight; (iv) Weight: body
weight in kg; (v) Length: contour body length in cm; (vi) PaCO2: partial pressure of arterial carbon dioxide in mmHg; (vii) BE: base excess in mmol/L; (viii)
Oxygen: supplementation with oxygen, yes, no. Regression coefficients for factors are relative coefficients such that: (i) β for Age (Two year olds) was
determined with β for Age (Yearlings) set to 0 for the Sweden dataset; (ii) β for Age (Yearlings) and for Age (Two year olds) were determined with β for Age
(Adults) set to 0 for the Sweden + Alberta dataset; (iii) β for Sex (Male) was determined with β for Sex (Female) set to 0; (iv) β for Drug (MTZ) was
determined with β for Drug (DZT) set to 0; and (v) β for Oxygen (Yes) was determined with β for Oxygen (No) set to 0.
doi:10.1371/journal.pone.0170764.t003
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bears anesthetized with DTZ would have lower PaCO2 values than bears anesthetized with
MTZ, but this association was dependent on concurrent changes in respiratory rate. Overall,
we found very little support for hypothesis 4.
Hypothesis 5: DTZ produces less cardio-respiratory depression and
quicker recovery of normal body temperature than MTZ
We detected bradycardia (< 50 beats per min), bradypnea (< 5 breaths per min), and hyper-
thermia (T 40˚C) as the main physiological alterations during the anesthesia of bears with
both anesthetic protocols. However, we observed differences between study areas (S2 Text).
Mean heart rate was lower in two-year-old bears than in yearlings among the Swedish
bears, but this age class difference was not apparent in the model derived from the combined
datasets (Table 4). Heart rate was positively associated with ordinal day of capture and with
rectal temperature in both datasets. It was also positively associated with respiratory rate in
both datasets, albeit non-significantly in the combined datasets (Table 4). Relative to heart
rates recorded at 15 min following drug administration, heart rates in both datasets were gen-
erally lower at subsequent time points. Heart rate was not differentially affected by anesthetic
protocol. Therefore, our prediction that DTZ would depress cardiovascular function (heart
rate) less than MTZ was not supported.
Mean respiratory rate was significantly higher in bears captured by helicopter in Sweden
than in bears captured by culvert trap in Alberta (Table 4). Respiratory rates were also affected
by an interaction between rectal temperature and age in bears from Sweden (i.e., higher respi-
ratory rates with increasing rectal temperatures in two-year-old bears), but this effect was not
evident in the model derived from the combined datasets. Respiratory rates in bears from Swe-
den were significantly lower at 45 min than the first recording at 15 min following drug
administration, and significantly higher at all time points from 90 to 135 min after drug
administration. Respiratory rate was not differentially affected by anesthetic protocol (Fig 3).
Fig 2. Partial pressure of arterial carbon dioxide (PaCO2, mmHg) by respiratory rate (breaths/minute) and drug
combination (MTZ: medetomidine-tiletamine-zolazepam; DTZ: dexmedetomidine-tiletamine-zolazepam) in 40
anesthetic events of free-ranging brown bears captured in Sweden and Alberta, Canada in 2014–2015.
doi:10.1371/journal.pone.0170764.g002
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Therefore, our prediction that DTZ would produce less depression of the respiratory function
(respiratory rate) than MTZ was not supported.
Rectal temperature was influenced positively by heart rate and negatively by time following
drug administration. For the combined datasets, two-year-old bears had significantly higher
rectal temperatures than adult bears (Table 4). Rectal temperature was not differentially
affected by anesthetic protocol. Therefore, our prediction that MTZ would increase rectal
Table 4. Regression coefficients (β) and significance (p) of the predictor variables in the best model explaining variation in the response variables
for hypothesis (H) 5 in brown bears anesthetized with either medetomidine-tiletamine-zolazepam (MTZ) or dexmedetomidine-tiletamine-zolaze-
pam (DTZ) in Sweden (n = 34) and Alberta, Canada (n = 6) in 2014–2015.
H5: Heart rate H5: Respiratory rate H5: Rectal temperature
Sweden Sweden + Alberta Sweden Sweden +
Alberta
Sweden Sweden +
Alberta
Predictorsa β p β p β p β p β p β p
Area (Sweden) 0.644 <0.001
Age (Yearlings) 37.415 0.092 0.529 0.161
Age (Two year olds) -23.334 0.013 8.200 0.696 0.004 0.976 1.161 0.002
Sex (Male) 6.232 0.215 4.837 0.247
Drug (MTZ) -0.694 0.869
Length -5.948 0.142 0.620 0.946
Length*Age (Yearlings) -9.142 0.508
Length*Age (Two year olds) 4.452 0.812
CD time 4.043 0.096
Ordinal day of capture 9.313 0.002 7.909 0.001
Induction time -4.40 0.242
Induction time*Sex (Male) 6.903 0.153
Surgery (Yes) -1.824 0.718
Ketamine dose level -3.324 0.175 -3.280 0.121
RT 5.134 <0.001 5.637 <0.001 -0.003 0.946
RT*Age (Two year olds) 0.381 <0.001
HR 0.370 <0.001 0.479 <0.001
RR 1.496 0.018 1.378 0.090
Time (30 minutes) -5.689 0.009 -2.985 0.154 -0.154 0.093 0.112 0.390 0.074 0.553
Time (45 minutes) -8.032 <0.001 -5.374 0.009 -0.182 0.044 -0.005 0.969 -0.003 0.982
Time (60 minutes) -7.205 0.002 -4.858 0.034 -0.148 0.119 -0.251 0.065 -0.234 0.083
Time (75 minutes) -6.866 0.003 -5.780 0.029 0.047 0.616 -0.523 <0.001 -0.428 <0.001
Time (90 minutes) -6.969 0.005 0.230 0.025 -0.695 <0.001
Time (105 minutes) -5.252 0.05 0.299 0.006 -0.966 <0.001
Time (120 minutes) -7-726 0.009 0.391 0.001 -1.024 <0.001
Time (135 min) -8.603 0.008 0.438 <0.001 -1.216 <0.001
a Predictor variables–(i) Area: Sweden, Alberta; (ii) Age: yearlings, two year olds, adults (5 yr); (iii) Sex: male, female; (vi) Drug: MTZ or DTZ in mg/kg body
weight; (v) Length: contour body length in cm; (vi) CD time: time interval in minutes from when active pursuit began to when the bear was darted; (vii)
Induction time: time interval in minutes from when a bear was darted to recumbency (viii) Surgery: yes or no; (ix) Ketamine dose level: in mg/kg body weight;
(x) RT: rectal temperature; (xi) HR: heart rate; (xii) RR: respiratory rate; (xii) Time: minutes after darting when measurements were recorded. Regression
coefficients for factors are relative coefficients such that: (i) β for Area (Sweden) was determined with β for Area (Alberta) set to 0; β for Age (Two year olds)
was determined with β for Age (Yearlings) set to 0 for the Sweden dataset; (iii) β for Age (Yearlings) and for Age (Two year olds) were determined with β for
Age (Adults) set to 0 for the Sweden + Alberta dataset; (iv) β for Sex (Male) was determined with β for Sex (Female) set to 0; (v) β for Drug (MTZ) was
determined with β for Drug (DZT) set to 0; (vi) β for Surgery (Yes) was determined with β for Surgery (No) set to 0; and (vii) β for Times (30–135 minutes)
were determined with β for Time (15 minutes) set to 0.
doi:10.1371/journal.pone.0170764.t004
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temperature more than DTZ was not supported and, more generally, all three predictions
under hypothesis 5 were not supported.
Atipamezole was used to end anesthesia in the two study areas (Sweden: 0.48 ± 0.21 mg/kg
body weight, Alberta: 0.27 ± 0.1 mg/kg body weight). The duration of anesthesia (time interval
from when a bear was darted to atipamezole administration) was longer in the bears captured
in Sweden (132 ± 43 min) compared to Alberta (83 ± 25 min). The time interval from atipame-
zole administration until the bear showed the first signs of recovery was only documented in
the bears captured with culvert trap in Alberta. Time of recovery was shorter in the DTZ
group (median of 13 (8–26) min vs. 28 (26–54) min in the MTZ group) but, due to the small
sample size, we did not perform a statistical analysis. No capture-related mortalities occurred
in the study bears during or within one month following anesthesia as determined from move-
ment data collected by GPS radio collars on study animals.
Discussion
Both MTZ and DTZ proved to be safe and reliable drug combinations for anesthetizing free-
ranging brown bears captured by helicopter and by culvert trap. However, we found no evi-
dence to support use of DTZ as the better anesthetic combination. Both protocols produced a
rapid onset of anesthesia, smooth induction, good analgesia and muscle relaxation, and
smooth predictable recovery. Furthermore, the bears achieved an adequate plane of anesthesia
for abdominal and subcutaneous surgeries, and muscle biopsies. We did not detect any bears’
reaction (i.e., increase in heart rate) to surgery.
Induction was smooth and adverse effects that could not be effectively treated were not
encountered with either combination. The induction time in the study bears increased with an
increasing dose level of TZ. This result could be explained since the bears receiving more than
one dart (i.e., a higher dose level of the anesthetic combination) were the bears that took longer
to achieve recumbency. When only bears anesthetized with a single dart were considered, the
induction time decreased with an increasing dose level of TZ in yearlings and adults. This is in
agreement with the results reported by Painer et al. (2012), where the length of the induction
Fig 3. Respiratory rate (breaths/minute) over time following administration by drug combination (MTZ:
medetomidine-tiletamine-zolazepam; DTZ: dexmedetomidine-tiletamine-zolazepam) in 34 anesthetic events of
free-ranging brown bears captured in Sweden in 2014–2015.
doi:10.1371/journal.pone.0170764.g003
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time in yearling brown bears anesthetized with one dart decreased with an increasing dose of
M. In our study, we did not prove that induction occurs faster in bears receiving DTZ than
MTZ. Therefore, we rejected our first hypothesis. Selmi et al. (2004) reported shorter times to
initial sedative effects in golden-lion tamarins anesthetized with D-ketamine compared to M-
ketamine. However, the same study found no difference in the time to lateral recumbency. In
addition, the time from darting to first signs of sedation and recumbency were similar in Ben-
nett’s wallabies (Macropus rufogriseus) and Chinese water deer (Hydropotes inermis) compar-
ing two groups of animals receiving M-ketamine or D-ketamine [17, 18]. Although there are
no previous comparisons of the effects of M and D in ursids, Teisberg et al. (2014) described
induction times in bears captured with helicopter and anesthetized with DTZ similar to times
found in studies using other drug combinations (xylazine-tiletamine-zolazepam, MTZ)
[29, 41].
In accordance with previous studies in brown bears [42], the need for supplemental drugs
to sustain anesthesia increased as the handling time increased. Using the same doses of MTZ
for subadults and slightly lower doses for yearlings, Fahlman et al. (2011) reported that bears
were sufficiently anesthetized to allow one hour of handling time. In our study in Sweden, the
mean handling time was 128 ± 42 min, and supplemental drugs were necessary to sustain anes-
thesia in 62% of the bears. However, the need for supplemental drug administration was simi-
lar between anesthetic protocols. Thus, we rejected our second hypothesis. In wildlife species,
a longer lasting anesthetic effect of D-ketamine over M-ketamine was discovered in golden-
lion tamarins [16]. On the contrary, no difference in the duration of anesthesia was observed
in wallabies and Chinese water deer at the time atipamezole was administered as reversal [17,
18]. Comparative studies between M and D have shown a longer lasting sedative effect of D in
dogs and cats [13, 43]. Although, more recent studies have failed to prove any difference, and
have concluded that M and D possess comparable sedative effects [44, 45].
Blood concentrations of cortisol, and glucose to a lesser extent, are widely-used parameters
to assess the stress response to capture and handling in free-ranging wild animals [23, 24].
During the stress response to capture, glucocorticoid steroid hormones (including cortisol)
are released into the blood circulation, and among their many effects is a sudden rise in blood
glucose levels (i.e., hyperglycemia) [46]. Alpha-2 adrenoceptor agonists can reduce the stress
of physical capture and handling due to their sedative effects (reduction of struggling and
improvement of muscle relaxation) [47]. On the other hand, it is well documented that the use
of alpha-2 adrenoceptor agonists increases plasma glucose concentrations through insulin
release inhibition [26, 48]. The role of alpha-2 adrenoceptor agonists on cortisol concentra-
tions is controversial, and varies among species [26, 27, 48–53]. Additionally, these studies sug-
gest that the drug effect might be age and dose-dependent. Based on our results, we would
suggest that bears with longer inductions, males, bears that weighed less, and bears captured
by culvert trap vs. helicopter were more stressed by the capture event. However, blood cortisol
concentrations did not support a lower stress response when using DTZ than when using
MTZ, thus rejecting our third hypothesis. However, due to a paucity of information on the
effect of alpha-2 adrenoceptor agonists, as well as TZ, in ursid species, caution should be
taken. When drawing conclusions about capture-related stress by using cortisol concentra-
tions in anesthetized animals, the potential for drug-induced effects should be considered.
We discovered acidemia (S3 Table) at similar levels to previous studies on brown bears cap-
tured by helicopter and anesthetized with MTZ in Scandinavia [29]. The reduction in pH val-
ues in our study can be attributed to a combination of respiratory and metabolic causes. The
physical exertion during capture was probably responsible for acid lactic production and
decrease of base excess values. This lead to a reduction in pH values due to metabolic acidosis
in the early stages of the capture. A reduction in the respiratory rate due to the alpha-2
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adrenoceptor agonists increased PaCO2 values causing respiratory acidosis. In our study, we
rejected our fourth hypothesis as higher pH did not occur in bears anesthetized with DZT
than MTZ.
We also documented hypoxemia (inadequate oxygen levels in the blood) which is a com-
mon physiological alteration found during the anesthesia of ursid species [7, 28, 29, 54]. The
use of alpha-2 adrenoceptor agonists can cause respiratory depression and produce intrapul-
monary changes that may result in hypoxemia [29, 55–57]. Hypoxemia can lead to hypoxia
(inadequate oxygen levels in the body) that can have life-threatening consequences, such as
myocardial ischemia, brain cell death and multi-organ damage [56, 58]. In the bears of the
study, oxygen supplementation improved oxygenation and effectively treated hypoxemia as
previously reported in brown bears [54, 59]. We found a decrease in PaO2 values with
increasing rectal temperatures, as hyperthermia increases oxygen consumption [58]. Addi-
tionally, PaO2 values decreased with an increasing body length (significant correlated to dose
level of alpha-2 adrenoceptor agonist). It is widely documented that effects of alpha-2 adreno-
ceptor agonists (i.e., sedation, analgesia, cardiovascular function) are dose-dependent [42, 55,
60, 61]. The alteration of the central and peripheral response to CO2 and oxygen is also dose-
dependent [62]. A previous study in brown bears suggested that the hypoxemia caused by M
could be dose-dependent [29]. Moreover, significantly lower PaO2 values were found when
high doses of M and D were administered to dogs compared to lower doses [15]. Recently,
studies using D in the anesthesia of bears found normal respiratory rates and high oxygen
saturations [21, 22]. These authors suggested a potential benefit of D over M in bears due to
less respiratory depression (i.e., hypoventilation, hypoxemia). However, these studies did not
include a comparison of performance or efficacy with equivalent doses of M. In our study
bears, contrary to Teisberg et al. (2014), both MTZ and DTZ caused hypoxemia (PaO2 < 80
mm Hg). We rejected our fourth hypothesis, as bears anesthetized with DTZ did not show
higher PaO2 than bears anesthetized with MTZ. We argue that the different findings between
Teisberg et al. (2014) and our study is due to the dose-dependent effect of alpha-2 adrenocep-
tor agonists on PaO2. The mean D dose level used in our study (21.97 ± 10.12 μg/kg in
Alberta, 57.51 ± 38.37 μg/Kg in Sweden) was two to five times higher than in Teisberg et al.
(2014) (10.11 ± 1.04 μg/Kg).
The hemoglobin oxygen saturation measured with pulse oximeter (SpO2) in the bears cap-
tured by culvert trap proved to be an unreliable indicator for hypoxemia in the study bears, as
shown in other studies involving wildlife species [59, 63, 64]. For example, in one bear we mea-
sured 95% SpO2 that corresponded with PaO2 value of 59 mmHg recorded at the same point
in time.
Values of PaCO2 represent the balance between cellular production of carbon dioxide
(CO2) and ventilatory removal of CO2. CO2 elimination depends on the respiratory rate and
the volume of inspired or expired air in one breath (tidal volume) [62]. Thus, we reported a
reduction in PaCO2 caused by increasing respiratory rates. Nevertheless, hypercapnia was a
more common physiological alteration documented in the study. PaCO2 values in our study
were similar to previously reported values in brown bears anesthetized with MTZ in Scandina-
via [29]. Mild to moderate hypercapnia may be beneficial in that it enhances the release of oxy-
gen from hemoglobin into the tissues. However, severe hypercapnia, can lead to impaired
myocardial contractility, narcosis, and coma [58]. PaCO2 values increased with increasing
PaO2 values (correlated to time from darting to sampling time). Although provision of supple-
mental oxygen causes PaO2 values to increase, it has little effect on hypercapnia. The elevation
of PaCO2 values usually indicates low respiratory rates (hypoventilation) that, in the study
bears, was probably caused by the alpha-2 adrenoceptor agonists [29, 55]. In relation to PaCO2
values, we observed a differential effect of the anesthetic protocol. In the DTZ group, PaCO2
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values decreased with increasing respiratory rates due to increased elimination of CO2. In con-
trast, PaCO2 values remained constant with increasing respiratory rates in the MZT group.
Additionally, we found, although not significant, higher PaCO2 values with increasing rectal
temperatures in the MTZ when data from Sweden and Alberta were combined. We believe
that the greater variation in rectal temperature in the combined datasets was due to the differ-
ent capture methods used, and therefore, made this interaction relevant. Furthermore, we
believe that increasing rectal temperatures reflect increasing respiratory rates, as demonstrated
in other studies with bears, where concurrent high respiratory rates and hyperthermia were
documented [9, 29]. Surprisingly, these findings were not supported by significantly different
respiratory rates between anesthetic protocols (i.e., higher respiratory rate in the DTZ group).
Thus, we suggest that the results regarding PaCO2 values may be caused by a differential drug
effect on the tidal volume (i.e., alveolar volume) and ventilation. The use of DTZ in the anes-
thesia of giant pandas (Ailuropoda melanoleuca) revealed changes in SpO2 with constant respi-
ratory rates [19], supporting the fact that changes in ventilation might occur independently of
respiratory rates. Anesthetic drugs can influence tidal volume by causing ventilation-perfusion
problems [62]. Ventilation-perfusion problems lead to a decrease in PaO2 levels before any
changes in PaCO2 levels. The administration of supplemental oxygen during anesthesia pre-
vented us from detecting this effect. These results provide partial support to our fourth hypoth-
esis that bears anesthetized with DTZ would have lower PaCO2 values than bears anesthetized
with MTZ. We believe that D resulted in better ventilation than M, but only when respiratory
rates increased. If this is true, D could prove more beneficial than M in situations when respi-
ratory rates are anticipated to increase as in captures involving pursuit with a helicopter, cap-
tures with high ambient temperatures, or in later stages of anesthesia and during recovery.
Nevertheless, we acknowledge that other comparative studies have not revealed differences
between the use of M and the use of D on arterial blood gases and acid-base status [15, 17, 18].
In this study, mean heart rates remained within normal ranges (50–120 beats per min, S4
and S5 Tables) during the anesthetic period although we did observe bradycardia and tachy-
cardia in some individual bears. Bradycardia secondary to vasoconstriction and hypertension
is a common effect of the administration of alpha-2 adrenoceptor agonists [55, 65, 66]. Heart
rates decreased over time as reported in previous studies [16, 20]. We also found lower heart
rates in two-year-old bears than in yearlings in Sweden. Similarly, age differences have been
previously reported in brown bears [29]. Brown bears in Scandinavia hibernate over a six-
month period [67]. During this period, the bears do not eat, drink, defecate or urinate, and
their metabolism is reduced. When bears emerge from the den after the hibernation period,
their metabolic rate is approximately 50% of its normal rate which occurs sometime in the
weeks following den emergence. For example, metabolic rate increased and stabilized 3 weeks
following den emergence in black bears [68]. During this period of increased metabolism,
heart rate, respiratory rate, body temperature, and movement rates increase [68, 69]. The bears
of the study were captured from April, shortly after den emergence, to July. Thus, an increase
in ordinal day of capture, accompanied by increasing rectal temperature and respiratory rate,
would explain the increase in heart rate (used as an indicator of metabolic rate) [70]. We did
not find fewer occurrences of bradycardia in bears receiving DTZ than in bears receiving
MTZ. Therefore, we rejected our fifth hypothesis. Similarly, studies on other wildlife species
have not found differences in the effect of M or D on heart rates [17, 18]. Selmi et al. (2004)
showed that the heart rate in tamarins receiving D-ketamine was significantly lower than in
the M-ketamine group. However, the authors attributed this result to different degrees of seda-
tion and analgesia. In cats and dogs, numerous studies have reported contradictory results in
comparing the effect of different doses of M and D on heart rate. For example, one study with
domestic cats concluded that D and M have equivalent therapeutic effects [13], while another
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reported greater mean heart rates for M compared with D five min after drug administration,
but mean heart rates were greater for D than for M at 180 min [44]. In dogs, Kuusela et al.
(2001) reported a lower overall heart rate (area under the heart rate versus time) for D versus
M in one of the dose levels (mg/kg) assessed but not in the others. These results suggest that
the effects of alpha-2 adrenoceptor agonists on heart rates depend upon species, dose level and
the time of measurement.
In this study, despite mean respiratory rates remaining within normal range (5–30 breaths/
min) during anesthesia, hypoventilation likely occurred based on the magnitude of increases
of PaCO2 values, and based on the respiratory rates reported in previous studies [29]. Similar
to what has been reported in other studies, respiratory rate decreased over the first hour of
anesthesia [16, 20, 29]. Respiratory rates increased after 90 min of anesthesia, probably due to
a compensatory mechanism for hypercapnia and/or a light plane of anesthesia. We discovered
higher respiratory rates in the Swedish bears than in the Alberta bears. This likely reflects the
use of different captured methods, helicopter in Sweden vs. culvert trap in Alberta. Captures
from helicopter often involve greater physical exertion with consequential increases in rectal
temperature and respiratory rate prior to drug administration [71]. Bears receiving DTZ did
not present lower respiratory rates than bears receiving MTZ. Hence, we rejected our fifth
hypothesis. As previously mentioned, studies using D found normal respiratory rates during
the anesthesia of bears [21, 22]. Bouts et al. (2011) also suggested that D would cause less respi-
ratory depression compared to M. Nevertheless, studies in other wildlife species, as well as in
domestic dogs and cats, have reported no differences in respiratory rates when comparing the
two alpha-2 adrenoceptor agonists [13, 16, 17, 44, 45]. However, a study of laboratory mice
reported higher respiratory rates in mice anesthetized with M-ketamine vs. D-ketamine [72].
We recorded body temperatures 40˚C in the bears of the study. The highest body temper-
ature recorded was 41.3˚C in the MTZ group in Sweden. Hyperthermia has been previously
reported in brown bears captured with helicopter [9, 29]. We found a significantly positive
effect of age on rectal temperatures, two-year-old bears presented higher temperatures than
yearlings and adult bears. This probably reflects the combined effect of a different capture
method (helicopter in Sweden vs. culvert trap in Alberta) and the age difference among the
bears of the two study areas (young bears in Sweden vs. adult bears in Alberta). Rectal temper-
atures in the Swedish bears were higher than in the Alberta bears due to physical exertion dur-
ing helicopter pursuit [71]. Fahlman et al. (2011) reported lower rectal temperatures in
yearling brown bears in comparison to subadults and adults. In our study, helicopter pursuit
caused an increase in rectal temperature that masked the age effects on body temperature
between yearlings in Sweden and adult bears captured in Alberta with culvert traps. Addition-
ally, ambient temperature could also be an influencing factor as all yearlings were captured in
April-May shortly after den emergence, while some two year olds were captured in July. Rectal
temperatures significantly decreased over time in accordance with previous reports [18, 20,
29]. However, hypothermia was not observed at any time. The lowest body temperature
recorded was 36.5˚C in the DTZ group in Sweden. The alteration of thermoregulatory mecha-
nisms by the alpha-2 adrenoceptor agonists [73], the cessation of physical activity, the onset of
drug-induced muscle relaxation, and the application of corrective measures to reduce body
temperature probably contributed to the decrease in body temperature [74]. Rectal tempera-
ture was not differentially affected by the drug combination used, hence, rejecting our fifth
hypothesis that bears anesthetized with DTZ would show a quicker recovery of normal body
temperature than MTZ. None of the studies comparing the effects of alpha-2 adrenoceptor
agonists on thermoregulation in wildlife species have demonstrated any difference [16–18,
20]. However, these studies were performed in captive settings, where the animals were not
subjected to high levels of physical exertion, and body temperatures were normal or close to
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normal at induction [17]. In free-ranging animals, especially those pursued during capture, we
expect hyperthermia at early stages, irrespective of the anesthetic protocol used, due to stress
and physical exertion. We also expect temperature to decrease and return to normal values
over time. This decrease, however, might be affected by the anesthetic protocol used through
the alteration of thermoregulatory mechanisms or changes in the respiratory rates [41, 75].
Drugs producing less depression of the respiratory function, would allow animals to better dis-
sipate heat, and return to normal temperature values quicker [76]. In our study, we observed
initial hyperthermia, and a decrease of rectal temperature over time as expected. Contrary to
our hypothesis, both MZT and DZT produced the same level of respiratory depression on the
bears, and therefore, no differences in rectal temperature between groups were detected at any
time.
In Alberta, the time of recovery was shorter in the DTZ group. However, the dose level of
atipamezole administered to the bears to reverse anesthesia was higher in the DZT (9.23 ±
1.08) than the MTZ group (7.85 ± 4.70). Furthermore, the sample size was small (n = 6). Thus,
no definitive conclusions can be drawn. Results of previous studies in regards to recovery time
are not in agreement. Some studies showed no difference in the recovery times [13, 72]. Other
studies found a faster recovery with M than D when using a half-dose of atipamezole to reverse
the effects of D [18]. Thus, the use of a full dose of atipamezole for D is recommended [18, 21].
When no reversal agent was used, Selmi et al. (2004) reported no differences in the time inter-
val between the end of anesthesia and the animal standing, but longer times from standing
until the animal could walk when using D in the anesthetic combination.
In summary, DZT and MZT produced reliable anesthesia without detectable differences
in induction time, the need for supplemental drugs to sustain anesthesia, capture-related
stress, acid-base status, PaO2, and physiological responses in free-ranging brown bears cap-
tured by helicopter or by culvert trap. DZT provided an apparent benefit by decreasing
PaCO2 levels with increasing respiratory rates. However, this advantage was not supported
by differential respiratory rates between anesthetic protocols. We recommend the use of sup-
plemental oxygen to treat hypoxemia at the dose levels of alpha-2 adrenoceptor agonists
used in the study. We conclude that dexmedetomidine offers no advantage over the use of
medetomidine in the anesthesia of free-ranging brown bears when combined with tileta-
mine-zolazepam.
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